ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Abera Bioscience is a Swedish biotechnology company that develops nasal vaccines based on a proprietary OMV-based platform technology. The company's focus is on nasal vaccines that provide immune responses in both mucosal and systemic areas. Abera develops vaccines against several respiratory infectious diseases, including pneumococci, influenza and pandemic preparedness, with projects in preclinical and planned clinical phases. The company was founded in 2012 and is headquartered in Uppsala.
Lue lisääEPS (oik.)
Osinko %
Yhtiökokous '26
Osavuosikatsaus Q2'26
Osavuosikatsaus Q3'26